This past year saw major shifts affecting patent adjudication, prosecution strategy, biotechnology claiming, artificial intelligence, standard-essential patents, and litigation trends....more
1/26/2026
/ Amgen v Sanofi ,
Artificial Intelligence ,
Biotechnology ,
Diagnostic Method ,
Inter Partes Review (IPR) Proceeding ,
Life Sciences ,
Patent Applications ,
Patent Examinations ,
Patent Litigation ,
Patent Prosecution ,
Patent Trial and Appeal Board ,
Patents ,
Section 101 ,
Standard Essential Patents ,
Trademarks ,
USPTO
Happy New Year from all of us at Wolf Greenfield.
In this episode of IP Talk with Wolf Greenfield, we take our annual look back at the year just concluded and ahead to the new year, 2026, just begun.
From anticipated...more
The US Patent and Trademark Office (USPTO) is navigating a period of significant transition. Driven by workforce shifts, operational restructuring, evolving approaches to subject matter eligibility, and new fee structures,...more
12/18/2025
/ Artificial Intelligence ,
Continuation Applications ,
Examiners ,
Fees ,
Filing Fees ,
Inter Partes Review (IPR) Proceeding ,
Involuntary Reduction in Force ,
IP Portfolio ,
Machine Learning ,
Patent Applications ,
Patent Examinations ,
Patent Fees ,
Patent Prosecution ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Prior Art ,
Remote Working ,
Section 101 ,
USPTO
2024 is upon us and it’s going to be another busy year for intellectual property law. In this episode of IP Talk with Wolf Greenfield, you’ll hear Wolf Greenfield attorneys from a variety of practice areas offering their...more
What should in-house counsel be on the lookout for in 2024? As we begin a new year, our attorneys look ahead at intellectual property topics they expect will be trending in 2024. They cover areas including life sciences,...more
1/4/2024
/ Artificial Intelligence ,
Biotechnology ,
Copyright ,
Design Patent ,
First Amendment ,
In-House Perspective ,
Intellectual Property Protection ,
International Trade Commission (ITC) ,
Life Sciences ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Post-Grant Review ,
Trademark Infringement ,
Trademarks ,
Unified Patent Court ,
Unitary Patent